Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBITDA Margin: 2013-2018

Historic EBITDA Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 326.71%.

  • Armata Pharmaceuticals' EBITDA Margin rose 1215171.00% to 326.71% in Q4 2018 from the same period last year, while for Dec 2018 it was 2,233.15%, marking a year-over-year increase of 1628184.00%. This contributed to the annual value of 762.14% for FY2024, which is 291085.00% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported EBITDA Margin of 326.71% as of Q4 2018, which was down 63.80% from 902.61% recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year EBITDA Margin high stood at 18,733.01% for Q3 2014, and its period low was -53,927.27% during Q4 2016.
  • Its 3-year average for EBITDA Margin is -11,016.01%, with a median of -4,262.26% in 2016.
  • In the last 5 years, Armata Pharmaceuticals' EBITDA Margin spiked by 148,276,634bps in 2014 and then slumped by 5,163,040bps in 2016.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' EBITDA Margin stood at -2,571.29% in 2014, then spiked by 27,441bps to -2,296.88% in 2015, then slumped by 5,163,040bps to -53,927.27% in 2016, then soared by 4,210,227bps to -11,825.00% in 2017, then soared by 1,215,171bps to 326.71% in 2018.
  • Its EBITDA Margin was 326.71% in Q4 2018, compared to 902.61% in Q3 2018 and 10,980.68% in Q2 2018.